Visit Store
Visit Store
Keep up with what’s new in medicine and healthcare publishing.
Elsevier Spotlight
Three new trials published in the past year have pushed the debate on the efficacy and safety of aspirin for primary prevention of cardiovascular disease (CVD) back to the forefront. Abdelaziz et al conducted an updated meta-analysis of recent large trials, including >45,000 individuals from the three new trials, to provide comprehensive and updated information on the efficacy and safety of aspirin for primary prevention of CVD.
News & Articles
Advances in Family Practice Nursing is the newest addition to the Elsevier Advances family. It continues the tradition of publishing original articles on current advances and breakthroughs within a specialty.
Elsevier Spotlight
Three new trials published in the past year have pushed the debate on the efficacy and safety of aspirin for primary prevention of cardiovascular disease (CVD) back to the forefront. Abdelaziz et al conducted an updated meta-analysis of recent large trials, including >45,000 individuals from the three new trials, to provide comprehensive and updated information on the efficacy and safety of aspirin for primary prevention of CVD.
Reviews

This is a comprehensive resource for anyone treating critically ill adults. MORE

Expert Perspectives

Explore the latest resources and learn from authors in your field.